Suppr超能文献

细胞外囊泡的治疗和诊断应用。

Therapeutic and diagnostic applications of extracellular vesicles.

机构信息

Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

出版信息

J Control Release. 2016 Dec 28;244(Pt B):167-183. doi: 10.1016/j.jconrel.2016.07.054. Epub 2016 Aug 2.

Abstract

During the past two decades, extracellular vesicles (EVs) have been identified as important mediators of intercellular communication, enabling the functional transfer of bioactive molecules from one cell to another. Consequently, it is becoming increasingly clear that these vesicles are involved in many (patho)physiological processes, providing opportunities for therapeutic applications. Moreover, it is known that the molecular composition of EVs reflects the physiological status of the producing cell and tissue, rationalizing their exploitation as biomarkers in various diseases. In this review the composition, biogenesis and diversity of EVs is discussed in a therapeutic and diagnostic context. We describe emerging therapeutic applications, including the use of EVs as drug delivery vehicles and as cell-free vaccines, and reflect on future challenges for clinical translation. Finally, we discuss the use of EVs as a biomarker source and highlight recent studies and clinical successes.

摘要

在过去的二十年中,细胞外囊泡 (EVs) 已被确定为细胞间通讯的重要介质,使生物活性分子能够从一个细胞传递到另一个细胞。因此,越来越明显的是,这些囊泡参与了许多(病理)生理过程,为治疗应用提供了机会。此外,已知 EVs 的分子组成反映了产生细胞和组织的生理状态,这使得它们可以作为各种疾病的生物标志物进行开发利用。在这篇综述中,我们讨论了 EVs 在治疗和诊断背景下的组成、生物发生和多样性。我们描述了新兴的治疗应用,包括将 EVs 用作药物传递载体和无细胞疫苗,并反思了临床转化的未来挑战。最后,我们讨论了将 EVs 用作生物标志物来源,并强调了最近的研究和临床成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验